| Non-invasive strategies for nose-to-brain drug delivery JT Trevino, RC Quispe, F Khan, V Novak Journal of clinical trials 10 (7), 2020 | 81 | 2020 |
| MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial V Novak, CS Mantzoros, P Novak, R McGlinchey, W Dai, V Lioutas, ... Journal of neurology 269 (9), 4817-4835, 2022 | 29 | 2022 |
| Use of radiofrequency ablation for the management of facial pain: a systematic review V Orhurhu, F Khan, RC Quispe, L Huang, I Urits, M Jones, O Viswanath, ... Pain Physician 23 (6), E559, 2020 | 20 | 2020 |
| Patient satisfaction following intrathecal targeted drug delivery for benign chronic pain: results of a single-center survey study DM Schultz, V Orhurhu, F Khan, JM Hagedorn, A Abd-Elsayed Neuromodulation: Technology at the Neural Interface 23 (7), 1009-1017, 2020 | 17 | 2020 |
| Use of radiofrequency ablation for the management of headache: a systematic review V Orhurhu, L Huang, RC Quispe, F Khan, J Karri, I Urits, J Hasoon, ... Pain Physician 24 (7), E973, 2021 | 13 | 2021 |
| Safety of intranasal insulin in type 2 diabetes on systemic insulin: a double-blinded placebo-controlled sub-study of memaid trial LA Becerra, BG Mendez, F Khan, V Lioutas, P Novak, CS Mantzoros, ... Archives of diabetes & obesity 4 (2), 403, 2022 | 3 | 2022 |
| Daily intranasal insulin at 40IU does not affect food intake and body composition: A placebo-controlled trial in older adults over a 24-week period with 24-weeks of follow-up LA Becerra, A Gavrieli, F Khan, P Novak, V Lioutas, LH Ngo, V Novak, ... Clinical Nutrition 42 (6), 825-834, 2023 | 2 | 2023 |
| Obesity trends amongst hospitalized patients with spinal cord stimulator implants V Orhurhu, F Khan, M Salisu Orhurhu, E Agudile, I Urits, J Hasoon, ... Advances in Therapy 37, 4614-4626, 2020 | 2 | 2020 |
| Intranasal Insulin Enhances Resting Neurovascular Fluctuations in Type 2 Diabetes Z Zhang, F Khan, P Novak, C Mantzoros, L Ngo, V Novak, W Dai | 1 | |
| Dropout risk and effectiveness of retention strategies in the Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID) Clinical Trial DF Isaza-Pierrotti, F Khan, P Novak, V Lioutas, CS Mantzoros, LH Ngo, ... Contemporary clinical trials 125, 107057, 2023 | | 2023 |
| 193-OR: Memory Advancement with Intranasal Insulin in Type 2 Diabetes: Randomized Control Trial V Novak, C Mantzoros, P Novak, R McGlinchey, W Dai, V Lioutas, S Buss, ... Diabetes 70 (Supplement_1), 2021 | | 2021 |
| 879-P: Dropout Risk and Effectiveness of Retention Strategies: A Substudy of the Memory Advancement by Intranasal Insulin (INI) in Type 2 Diabetes (MemAID) F Khan, DF Isaza-Pierotti, P Novak, C Mantzoros, LH Ngo, V Novak Diabetes 70 (Supplement_1), 2021 | | 2021 |
| 718-P: Long-Term Safety of Intranasal Insulin (INI) in Insulin-Dependent Type 2 Diabetes (T2DM-IDDM): A Safety Substudy of Memory Advancement by Intranasal Insulin in Type 2 … LA Becerra, BG Mendez, F Khan, C Mantzoros, P Novak, V Lioutas, ... Diabetes 70 (Supplement_1), 2021 | | 2021 |
| 719-P: Caloric Intake, Appetite, and Body Composition Outcomes of Long-Term Intranasal Insulin (INI) Administration: A Substudy of the Memory Advancement by INI in Type 2 … LA Becerra, F Khan, LH Ngo, V Novak, C MANTZOROS, ... Diabetes 70 (Supplement_1), 2021 | | 2021 |
| STRATEGIES FOR NOSE-TO-BRAIN DRUG DELIVERY RC Quispe, JA Trevino, F Khan, V Novak | | |
